Cellectis (CLLS) Other Accumulated Expenses (2013 - 2026)

Cellectis' Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $8.2 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 25.21% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $8.2 million (up 25.21% YoY), while the FY2025 annual figure was $12.3 million, up 22.23% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $8.2 million, down from $12.3 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $13.2 million in Q4 2022, with the low at $6.1 million in Q1 2023.
• The 5-year median for Other Accumulated Expenses is $9.9 million (2025), against an average of $9.6 million.
• The sharpest annual moves came in 2023 and 2026: Other Accumulated Expenses plunged 34.06% in 2023, then advanced 25.21% in 2026.
• Cellectis' Other Accumulated Expenses stood at $13.2 million in 2022, then slipped by 22.46% to $10.2 million in 2023, then declined by 1.19% to $10.1 million in 2024, then grew by 22.23% to $12.3 million in 2025, then sank by 33.4% to $8.2 million in 2026.
• Business Quant data shows CLLS's Other Accumulated Expenses at $8.2 million in Q1 2026, $12.3 million in Q4 2025, and $10.8 million in Q3 2025.